With over 18 years leading finance organizations and developing growth strategies for companies in the ophthalmic space, Michael Marquez serves as Chief Financial Officer for Nanoscope. Prior to joining Nanoscope Therapeutics, Mr. Marquez was CFO of TearLab, an ophthalmic diagnostics company with a point-of-care osmolarity test to aid in the diagnosis of dry eye disease. He also served as CFO of Global Surgical at Alcon Laboratories, a global medical company specializing in eye care products. Prior to Alcon, Mr. Marquez worked for Price Waterhouse Coopers serving tax and audit clients in the insurance and manufacturing sectors. 

Mr. Marquez holds a Master of Science in Accounting from The University of Texas at Arlington, and a Bachelor of Business Administration in Accounting from The University of Texas at Austin. He is a licensed Certified Public Accountant in Texas.